For the quarter ended March 2024, Cardinal Well being (CAH) reported income of $54.91 billion, up 8.8% over the identical interval final 12 months. EPS got here in at $2.08, in comparison with $1.74 within the year-ago quarter.
The reported income represents a shock of -1.63% over the Zacks Consensus Estimate of $55.82 billion. With the consensus EPS estimate being $1.95, the EPS shock was +6.67%.
Whereas buyers carefully watch year-over-year modifications in headline numbers — income and earnings — and the way they examine to Wall Avenue expectations to find out their subsequent plan of action, some key metrics at all times present a greater perception into an organization’s underlying efficiency.
Since these metrics play an important function in driving the top- and bottom-line numbers, evaluating them with the year-ago numbers and what analysts estimated about them helps buyers higher venture a inventory’s value efficiency.
Right here is how Cardinal carried out within the simply reported quarter by way of the metrics most generally monitored and projected by Wall Avenue analysts:
- Income- Pharmaceutical: $50.65 billion in comparison with the $51.89 billion common estimate primarily based on 4 analysts. The reported quantity represents a change of +8.2% 12 months over 12 months.
- Income- Medical: $3.11 billion versus $3.61 billion estimated by 4 analysts on common. In comparison with the year-ago quarter, this quantity represents a -15.5% change.
- Income- Company: -$20 million versus the three-analyst common estimate of -$2.73 million. The reported quantity represents a year-over-year change of +233.3%.
- Section profit- Medical: $20 million versus the four-analyst common estimate of $103.19 million.
- Section profit- Pharmaceutical: $580 million versus $606.65 million estimated by 4 analysts on common.
View all Key Company Metrics for Cardinal here>>>
Shares of Cardinal have returned -7.9% over the previous month versus the Zacks S&P 500 composite’s -4.2% change. The inventory presently has a Zacks Rank #3 (Maintain), indicating that it may carry out in keeping with the broader market within the close to time period.
7 Greatest Shares for the Subsequent 30 Days
Simply launched: Consultants distill 7 elite shares from the present listing of 220 Zacks Rank #1 Robust Buys. They deem these tickers “Most Seemingly for Early Worth Pops.”
Since 1988, the complete listing has overwhelmed the market greater than 2X over with a median achieve of +24.2% per 12 months. So be sure you give these hand picked 7 your rapid consideration.
Cardinal Health, Inc. (CAH) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.
